Epitope shift of proteinase-3 anti-neutrophil cytoplasmic antibodies in patients with small vessel vasculitis

Clinical and Experimental Immunology

Volumn 160, Issue 3, 2010, Pages 318-324

  Selga, D ^a   Segelmark, M ^a   Gunnarsson, L ^a   Hellmark, T ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

ANCA; Epitope; Proteinase 3; Vasculitis; Wegener's granulomatosis

Indexed keywords

EPITOPE; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD SAMPLING; CARBOXY TERMINAL SEQUENCE; CHILD; CLINICAL ARTICLE; DEATH; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SCORING SYSTEM; SMALL VESSEL VASCULITIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASES; CHILD; EPITOPES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOBLASTIN; PROSPECTIVE STUDIES; PROTEIN STRUCTURE, TERTIARY; RETROSPECTIVE STUDIES; VASCULITIS;

EID: 77952196152     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.04063.x     Document Type: Article

References (22)

1. van der Woude FJ. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet 1985 2 : 48. (Pubitemid 15067183)
2. Tervaert JW, van der Woude FJ, Fauci AS et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989 149 : 2461 2465. (Pubitemid 19283202)
3. Jayne DR, Gaskin G, Pusey CD, Lockwood CM. ANCA and predicting relapse in systemic vasculitis. Q J Med 1995 88 : 127 133.
4. Boomsma MM, Stegeman CA, van der Leij MJ et al. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000 43 : 2025 2033.
5. Segelmark M, Phillips BD, Hogan SL, Falk RJ, Jennette JC. Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis. Clin Diagn Lab Immunol 2003 10 : 769 774. (Pubitemid 37129485)
6. Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Rheumatology (Oxf) 2006 45 : 724 729.
7. Finkielman JD, Merkel PA, Schroeder D et al. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med 2007 147 : 611 619. (Pubitemid 351664480)
8. Bini P, Gabay JE, Teitel A, Melchior M, Zhou JL, Elkon KB. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. J Immunol 1992 149 : 1409 1415.
9. Griffith ME, Coulthart A, Pemberton S, George AJ, Pusey CD. Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site. Clin Exp Immunol 2001 123 : 170 177. (Pubitemid 32118854)
10. Van Der Geld YM, Simpelaar A, Van Der Zee R et al. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides. Kidney Int 2001 59 : 147 159. (Pubitemid 32055223)
11. Hellmark T, Segelmark M, Unger C, Burkhardt H, Saus J, Wieslander J. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. Kidney Int 1999 55 : 936 944. (Pubitemid 29100705)
12. Selga D, Segelmark M, Wieslander J, Gunnarsson L, Hellmark T. Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins. Clin Exp Immunol 2004 135 : 164 172. (Pubitemid 38067942)
13. Watts R, Lane S, Hanslik T et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007 66 : 222 227. R (Pubitemid 46226058)
14. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994 87 : 671 678.
15. Exley AR, Bacon PA, Luqmani RA et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997 40 : 371 380.
16. Williams RC Jr., Staud R, Malone CC, Payabyab J, Byres L, Underwood D. Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis. J Immunol 1994 152 : 4722 4737. (Pubitemid 24134434)
17. Chang L, Binos S, Savige J. Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies. Clin Exp Immunol 1995 102 : 112 119.
18. Garwicz D, Lindmark A, Hellmark T, Gladh M, Jogi J, Gullberg U. Characterization of the processing and granular targeting of human proteinase 3 after transfection to the rat RBL or the murine 32D leukemic cell lines. J Leukoc Biol 1997 61 : 113 123. (Pubitemid 27079474)
19. Specks U, Fass DN, Fautsch MP, Hummel AM, Viss MA. Recombinant human proteinase 3, the Wegener's autoantigen, expressed in HMC-1 cells is enzymatically active and recognized by c-ANCA. FEBS Lett 1996 390 : 265 270. (Pubitemid 26248957)
20. Sun J, Fass DN, Viss MA et al. A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide. Clin Exp Immunol 1998 114 : 320 326. (Pubitemid 28505735)
21. Specks U, Fass DN, Finkielman JD et al. Functional significance of Asn-linked glycosylation of proteinase 3 for enzymatic activity, processing, targeting, and recognition by anti-neutrophil cytoplasmic antibodies. J Biochem (Tokyo) 2007 141 : 101 112. (Pubitemid 46580160)
22. Rarok AA, van der Geld YM, Stegeman CA, Limburg PC, Kallenberg CG. Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology. J Clin Immunol 2003 23 : 460 468.